Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Genfit S.A. ADR (NQ: GNFT )

4.180 -0.140 (-3.24%)
Streaming Delayed Price Updated: 10:39 AM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,916
Open 4.240
Bid (Size) 4.190 (7)
Ask (Size) 4.230 (3)
Prev. Close 4.320
Today's Range 4.180 - 4.240
52wk Range 3.062 - 5.050
Shares Outstanding 38,888,379
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
On Friday, FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits of Intercept Pharmaceutical Inc's ICPT Ocaliva 25 mg, also known as Obeticholic acid... 
Via Benzinga
Earnings Scheduled For April 13, 2023
Companies Reporting Before The Bell • Northern Technologies (NASDAQ:NTIC) is estimated to report quarterly earnings at $0.18 per share on revenue of $20.40 million. 
Via Benzinga

Performance

YTD
-1.65%
-1.65%
1 Month
-2.16%
-2.16%
3 Month
-4.51%
-4.51%
6 Month
+18.41%
+18.41%
1 Year
+4.76%
+4.76%

More News

Read More
The 7 Best Biotech Stocks to Buy for February 2023
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases
Via Benzinga
Earnings Scheduled For September 28, 2022
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
US Stock Futures Rise After Recording Worst Sell-Off Since June 2020; PPI Data In Focus
Via Benzinga
BRP, Conformis And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
Via Benzinga
GENFIT Gets FDA Orphan Drug Status For Liver Disease Candidate
Via Benzinga
Analyzing Genfit's Short Interest
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
55 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
22 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For April 7, 2022
Via Benzinga
Banned diamonds
Via Talk Markets
Monday Markets News
Via Talk Markets
Lucky Day
Via Talk Markets
Gold up, Stocks down
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.